---
schema_version: "secwatch.filing_event.v1"
accession: "0001729149-25-000101"
form_type: "8-K"
ticker: "VMD"
cik: "0001729149"
company_name: "VIEMED HEALTHCARE, INC."
filed_at: "2025-06-09T23:59:59+00:00"
generated_at: "2026-05-19T17:19:33.143980+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Viemed authorizes share repurchase of up to 1.98M shares (~5% of outstanding) through June 2026

## Summary
- Board authorized repurchase of up to 1,976,441 common shares (approx. 5% of outstanding) through June 2026.
- Company has no net debt and full $55M credit facility available to fund repurchases and growth.
- CEO cited strong Q1 2025 results, increased 2025 guidance, and disciplined capital allocation.
- Acquisition of Lehan's Medical expected to close in Q3 2025; company repurchased ~2.6M shares since listing.

## SEC filing metadata
- accession: 0001729149-25-000101
- form_type: 8-K
- ticker: VMD
- cik: 0001729149
- company_name: VIEMED HEALTHCARE, INC.
- filed_at: 2025-06-09T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 8.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1729149/000172914925000101/0001729149-25-000101-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1729149/000172914925000101/vmd-20250606.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001729149-25-000101
- JSON: https://secwatch.observer/filing/0001729149-25-000101.json
- Plain text: https://secwatch.observer/filing/0001729149-25-000101.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.